First Turn Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.48M Buy
+501,724
New +$7.5M 1.13% 35

Other funds holding SMMT

First Turn Management's SMMT Position: Q3 2026 in Review

First Turn Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 501,724 shares worth $8.48M. The stake represents 1.13% of the portfolio and ranks #35 among its holdings.

296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • First Turn Management held 501,724 shares of Summit Therapeutics worth $8.48M as of Q3 2026.
  • Summit Therapeutics was a new First Turn Management position in Q3 2026.
  • Summit Therapeutics made up 1.13% of First Turn Management's portfolio in Q3 2026, its #35 holding.
  • 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on First Turn Management's 13F filing for Q3 2026, filed 16 Nov 2026.